Raymond James Downgrades Evoqua Water, Xylem; Turns Bullish On TPI Composites

Raymond James analyst Pavel Molchanov downgraded Evoqua Water Technologies Corp AQUA to Market Perform from Outperform without a price target.
The analyst notes, with Evoqua having been the best-performing stock in the firm's coverage last year and nearly reaching the previous price target of $50, he believes that the company's mid-single-digit organic growth story and bolt-on M&A opportunities are appropriately priced in.
The analyst downgraded Xylem Inc XYL to Underperform from Market Perform.
Molchanov says the stock is trading at the richest valuation in the peer group, and in the context of the firm's view that 2022 will be a better year for high-beta story stocks, he thinks that Xylem ought to be a source of funds.
The analyst upgraded TPI Composites Inc TPIC from Outperform to Strong Buy and lowered the price target to $25 (an upside of 63%) from $40.
The analyst lowered View Inc's VIEW price target to $7 (an upside of 85.6%) from $9 and maintained an Outperform rating on the shares.
Price Action: AQUA shares are trading lower by 3.18% at $46.34, XYL higher by 1.21% at $118.30, TPIC higher by 1.79% at $15.32, and VIEW is down 2.33% at $3.77 on the last check on Tuesday.

Analyst Calendar